Deva Holding A.S. (IST:DEVA)

Market Cap	11.92B
Revenue (ttm)	15.46B
Net Income (ttm)	69.42M
Shares Out	200.02M
EPS (ttm)	0.35
PE Ratio	171.73
Forward PE	n/a
Dividend	0.29 (0.49%)
Ex-Dividend Date	Jun 25, 2024

Volume	196,579
Average Volume	1,105,447
Open	59.45
Previous Close	59.70
Day's Range	59.45 - 60.45
52-Week Range	53.55 - 106.00
Beta	-0.05
RSI	39.26
Earnings Date	Mar 4, 2025

About Deva Holding A.S.

Deva Holding A.S. engages in the manufacturing, marketing, and sales of pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.